189 related articles for article (PubMed ID: 1923521)
1. Transformation by carboxyl-deleted Myb reflects increased transactivating capacity and disruption of a negative regulatory domain.
Hu YL; Ramsay RG; Kanei-Ishii C; Ishii S; Gonda TJ
Oncogene; 1991 Sep; 6(9):1549-53. PubMed ID: 1923521
[TBL] [Abstract][Full Text] [Related]
2. Detection of proteins that bind to the leucine zipper motif of c-Myb.
Favier D; Gonda TJ
Oncogene; 1994 Jan; 9(1):305-11. PubMed ID: 8302594
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional activation potential of normal and tumor-associated myb isoforms does not correlate with their ability to block GCSF-induced terminal differentiation of murine myeloid precursor cells.
Patel G; Tantravahi R; Oh IH; Reddy EP
Oncogene; 1996 Sep; 13(6):1197-208. PubMed ID: 8808694
[TBL] [Abstract][Full Text] [Related]
4. The carboxy-terminal domain of c-Myb activates reporter gene expression in yeast.
Seneca S; Punyammalee B; Sureau A; Perbal B; Dvorák M; Crabeel M
Oncogene; 1993 Sep; 8(9):2335-42. PubMed ID: 8361752
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional activation by human c-myb and v-myb genes.
Kalkbrenner F; Guehmann S; Moelling K
Oncogene; 1990 May; 5(5):657-61. PubMed ID: 2189102
[TBL] [Abstract][Full Text] [Related]
6. The myb oncogene.
Lipsick JS; Baluda MA
Gene Amplif Anal; 1986; 4():73-98. PubMed ID: 3333362
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation by the carboxyl terminus of c-Myb depends upon both the Myb DNA-binding domain and the DNA recognition site.
Dubendorff JW; Lipsick JS
Oncogene; 1999 Jun; 18(23):3452-60. PubMed ID: 10376523
[TBL] [Abstract][Full Text] [Related]
8. Increase in specific DNA binding by carboxyl truncation suggests a mechanism for activation of Myb.
Ramsay RG; Ishii S; Gonda TJ
Oncogene; 1991 Oct; 6(10):1875-9. PubMed ID: 1923510
[TBL] [Abstract][Full Text] [Related]
9. Human c-myb is expressed in cervical carcinomas and transactivates the HPV-16 promoter.
Nürnberg W; Artuc M; Nawrath M; Lovric J; Stüting S; Moelling K; Czarnetzki BM; Schadendorf D
Cancer Res; 1995 Oct; 55(19):4432-7. PubMed ID: 7671256
[TBL] [Abstract][Full Text] [Related]
10. Characterization of alternate and truncated forms of murine c-myb proteins.
Ramsay RG; Ishii S; Nishina Y; Soe G; Gonda TJ
Oncogene Res; 1989; 4(4):259-69. PubMed ID: 2549488
[TBL] [Abstract][Full Text] [Related]
11. c-Myb and v-Myb are differentially phosphorylated by p42mapk in vitro.
Aziz N; Wu J; Dubendorff JW; Lipsick JS; Sturgill TW; Bender TP
Oncogene; 1993 Aug; 8(8):2259-65. PubMed ID: 8336948
[TBL] [Abstract][Full Text] [Related]
12. Murine myeloid leukemias with aberrant myb loci show heterogeneous expression of novel myb proteins.
Dudek H; Reddy EP
Oncogene; 1989 Dec; 4(12):1489-95. PubMed ID: 2480562
[TBL] [Abstract][Full Text] [Related]
13. Nucleotide sequence of chicken c-myb complementary DNA and implications for myb oncogene activation.
Rosson D; Reddy EP
Nature; 1986 Feb 13-19; 319(6054):604-6. PubMed ID: 3753748
[TBL] [Abstract][Full Text] [Related]
14. Only late, nonmitotic stages of granulocyte differentiation in 32Dcl3 cells are blocked by ectopic expression of murine c-myb and its truncated forms.
Bies J; Mukhopadhyaya R; Pierce J; Wolff L
Cell Growth Differ; 1995 Jan; 6(1):59-68. PubMed ID: 7536440
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic activation of c-Myb by carboxyl-terminal truncation leads to decreased proteolysis by the ubiquitin-26S proteasome pathway.
Bies J; Wolff L
Oncogene; 1997 Jan; 14(2):203-12. PubMed ID: 9010222
[TBL] [Abstract][Full Text] [Related]
16. Murine myeloid leukemic cells with disrupted myb loci show splicing anomalies that account for heterogeneous sizes in myb proteins.
Tantravahi R; Dudek H; Patel G; Reddy EP
Oncogene; 1996 Sep; 13(6):1187-96. PubMed ID: 8808693
[TBL] [Abstract][Full Text] [Related]
17. c-Myb prevents TPA-induced differentiation and cell death in v-Myb transformed monoblasts.
Smarda J; Lipsick JS
Oncogene; 1994 Jan; 9(1):237-45. PubMed ID: 8302585
[TBL] [Abstract][Full Text] [Related]
18. Induction of B cell lymphomas by overexpression of a Myb oncogene truncated at either terminus.
Press RD; Wisner TW; Ewert DL
Oncogene; 1995 Aug; 11(3):525-35. PubMed ID: 7630637
[TBL] [Abstract][Full Text] [Related]
19. Identification of alternatively spliced transcripts for human c-myb: molecular cloning and sequence analysis of human c-myb exon 9A sequences.
Dasgupta P; Reddy EP
Oncogene; 1989 Dec; 4(12):1419-23. PubMed ID: 2687764
[TBL] [Abstract][Full Text] [Related]
20. Protein truncation is required for the activation of the c-myb proto-oncogene.
Grässer FA; Graf T; Lipsick JS
Mol Cell Biol; 1991 Aug; 11(8):3987-96. PubMed ID: 2072904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
